Brought to you by 
Claros Diagnostics gets $7.8mm in Series A round
05 Feb 2007
Executive Summary
Claros Diagnostics (point-of-care testing) raised $7.8mm through its Series A financing round. Oxford Bioscience led and was joined by Bioventures Investors, Accelerated Technologies, and Commons Capital.
Deal Industry
- Biotechnology
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Claros Diagnostics gets $7.8mm in Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice